Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma

被引：4
|
作者：
Gray, Steven G. [1 ]
Meirson, Tomer [2 ]
Mutti, Luciano [3 ,4 ]
机构：
[1] St James Hosp, Trinity St Jamess Canc Inst, Thorac Oncol Res Grp, Dublin, Ireland
[2] Beilinson Med Ctr, Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel
[3] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Coppito Bldg,Second Floor Via Vetorio SNC, I-67100 Laquila, Italy
[4] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Hlth Res Org, Philadelphia, PA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 04期
关键词：
MALIGNANT PLEURAL MESOTHELIOMA; THORACIC ONCOLOGY PLATFORM; CHEMOTHERAPY; PEMBROLIZUMAB;
D O I：
10.1016/j.jtho.2024.01.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：541 / 546
页数：6
相关论文
共 50 条
  • [21] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [22] Real-world apremilast experience in Australia
    Berry, William
    Baker, Chris
    Foley, Peter
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB240 - AB240
  • [23] Quantifying the diagnostic pathway for patients with cognitive impairment: real-world data from Australia
    Black, Christopher M.
    Woodward, Michael
    Ambegaonkar, Baishali M.
    Philips, Alana
    Pike, James
    Jones, Eddie
    Husbands, Joseph
    Khandker, Rezaul K.
    INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 (05) : 601 - 610
  • [24] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan K. V. C. C.
    Turner, CassieC. T.
    Hughes, BrettB. H.
    Houston, Kathleen K. H.
    Lwin, Zarnie Z. L.
    Chan, Bryan B. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 159 - 159
  • [25] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan
    Turner, Cassie
    Hughes, Brett
    Houston, Kathleen
    Lwin, Zarnie
    Chan, Bryan
    RESPIROLOGY, 2023, 28 : 25 - 25
  • [26] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan
    Turner, Cassie
    Hughes, Brett
    Lwin, Zarnie
    Chan, Bryan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (06) : 723 - 730
  • [27] Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
    Kim, Roger Y.
    Mitra, Nandita
    Bagley, Stephen J.
    Marmarelis, Melina E.
    Haas, Andrew R.
    Rendle, Katharine A.
    Vachani, Anil
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
  • [28] Recovering the real-world density and liquidity premia from option data
    Barkhagen, Mathias
    Blomvall, Joergen
    Platen, Eckhard
    QUANTITATIVE FINANCE, 2016, 16 (07) : 1147 - 1164
  • [29] Real-World Prognostic & Predictive Implications of EORTC & MRS Scores for Immunotherapy and Chemotherapy in Pleural Mesothelioma (PM)
    Wu, F. T. H.
    D'Amours, M. -F.
    Usman, F.
    Hussein, A.
    Bhang, E.
    Sarvestani, M. Kamali
    Lee, C. W.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S409 - S409
  • [30] Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
    Holzknecht, Arnulf
    Illini, Oliver
    Hochmair, Maximilian J.
    Krenbek, Dagmar
    Setinek, Ulrike
    Huemer, Florian
    Bitterlich, Erwin
    Kaindl, Christoph
    Getman, Vladyslav
    Akan, Ahmet
    Weber, Michael
    Leobacher, Gunther
    Valipour, Arschang
    Mueller, Michael R.
    Watzka, Stefan B.
    CANCERS, 2022, 14 (09)
12345